Inhibitor Therapeutics, Inc.
INTI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042418
No open-market purchases or sales by Inhibitor Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding INTI, Q2 2026
No superinvestor reported holding INTI at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Inhibitor Therapeutics, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Inhibitor Therapeutics, Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Inhibitor Therapeutics, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding INTI in 13F filings for Q2 2026.